236 related articles for article (PubMed ID: 27746365)
1. The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.
Chen X; Lu P; Wang DD; Yang SJ; Wu Y; Shen HY; Zhong SL; Zhao JH; Tang JH
Gene; 2016 Dec; 595(2):221-226. PubMed ID: 27746365
[TBL] [Abstract][Full Text] [Related]
2. miR-4443 Participates in the Malignancy of Breast Cancer.
Chen X; Zhong SL; Lu P; Wang DD; Zhou SY; Yang SJ; Shen HY; Zhang L; Zhang XH; Zhao JH; Tang JH
PLoS One; 2016; 11(8):e0160780. PubMed ID: 27504971
[TBL] [Abstract][Full Text] [Related]
3. Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old archived formalin-fixed paraffin-embedded specimens.
Peskoe SB; Barber JR; Zheng Q; Meeker AK; De Marzo AM; Platz EA; Lupold SE
BMC Cancer; 2017 Jan; 17(1):32. PubMed ID: 28061773
[TBL] [Abstract][Full Text] [Related]
4. Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.
Yin JY; Deng ZQ; Liu FQ; Qian J; Lin J; Tang Q; Wen XM; Zhou JD; Zhang YY; Zhu XW
Int J Clin Exp Pathol; 2014; 7(7):4261-7. PubMed ID: 25120807
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
6. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.
Boisen MK; Dehlendorff C; Linnemann D; Schultz NA; Jensen BV; Høgdall EV; Johansen JS
BMC Cancer; 2015 Dec; 15():1024. PubMed ID: 26714641
[TBL] [Abstract][Full Text] [Related]
8. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.
Kapodistrias N; Mavridis K; Batistatou A; Gogou P; Karavasilis V; Sainis I; Briasoulis E; Scorilas A
Oncotarget; 2017 Jan; 8(4):6896-6913. PubMed ID: 28036291
[TBL] [Abstract][Full Text] [Related]
9. Methods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues.
Gomes BC; Santos B; Rueff J; Rodrigues AS
Methods Mol Biol; 2016; 1395():189-205. PubMed ID: 26910075
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
11. Expression level of miR-93 in formalin-fixed paraffin-embedded tissues of breast cancer patients.
Deng ZQ; Qian J; Liu FQ; Lin J; Shao R; Yin JY; Tang Q; Zhang M; He L
Genet Test Mol Biomarkers; 2014 May; 18(5):366-70. PubMed ID: 24606013
[TBL] [Abstract][Full Text] [Related]
12. Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma.
Strauss P; Marti HP; Beisland C; Scherer A; Lysne V; Leh S; Flatberg A; Koch E; Beisvag V; Landolt L; Skogstrand T; Eikrem Ø
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534467
[TBL] [Abstract][Full Text] [Related]
13. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors.
Tanic M; Yanowski K; Gómez-López G; Rodriguez-Pinilla MS; Marquez-Rodas I; Osorio A; Pisano DG; Martinez-Delgado B; Benítez J
Int J Cancer; 2015 Feb; 136(3):593-602. PubMed ID: 24917463
[TBL] [Abstract][Full Text] [Related]
16. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.
Loudig O; Wang T; Ye K; Lin J; Wang Y; Ramnauth A; Liu C; Stark A; Chitale D; Greenlee R; Multerer D; Honda S; Daida Y; Spencer Feigelson H; Glass A; Couch FJ; Rohan T; Ben-Dov IZ
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335433
[TBL] [Abstract][Full Text] [Related]
18. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.
Teoh SL; Das S
Curr Pharm Des; 2017; 23(12):1845-1859. PubMed ID: 28231756
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
[TBL] [Abstract][Full Text] [Related]
20. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
